Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY, FIMM | Sorafenib |
CTRPv2 | sorafenib |
PharmacoGx | Sorafenib |
Database | Identifier |
---|---|
Smiles: | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F |
Inchikey: | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
Pubchem: | 216239 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SV2A | FIMM | pan-cancer | AAC | 0.44 | 0.01 |
mRNA | FAM110D | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | P2RY13 | FIMM | pan-cancer | AAC | 0.43 | 0.01 |
mRNA | VKORC1L1 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | TBXAS1 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | MRPL33 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | REEP4 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | BTG1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | AGFG1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | SFMBT2 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |